Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
New England Journal of Medicine · 09.10.2025 · 393 (14) · 1363-1374
DOI: 10.1056/nejmoa2507109 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 09.10.2025. Verfasst von John M Flack und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Population Science and Policy, Division of General Internal Medicine, Hypertension Section, Southern Illinois University,…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Cytochrome P-450 CYP11B2, Hypertension. Die Arbeit wurde bisher 190-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Medicine and Population Science and Policy, Division of General Internal Medicine, Hypertension Section, Southern Illinois University, Springfield.
- Université Paris Cité, INSERM Centre d'Investigation Clinique 1418, Paris.
- Assistance Publique-Hôpitaux de Paris, Department of Hypertension, Hôpital Européen Georges Pompidou, Paris.
- Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston.
- Division of Nephrology and Hypertension, University of Utah, Salt Lake City.
- Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Warsaw, Poland.
ORCID-Profile: Janet Wittes, Bryan Williams
Förderung
- Department of Health
- AstraZeneca
Zitieren
APA
Flack, J. M., Azizi, M., Brown, J. M., Dwyer, J. P., Fronczek, J., Jones, E. S. W., Olsson, D. S., Perl, S., Shibata, H., Wang, J. G., Wilderäng, U., Wittes, J., Williams, B., & BaxHTN Investigators (2025). Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. New England Journal of Medicine, 393(14), 1363-1374. https://doi.org/10.1056/nejmoa2507109
Vancouver
Flack JM, Azizi M, Brown JM, Dwyer JP, Fronczek J, Jones ESW, et al. Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. New England Journal of Medicine. 2025;393(14):1363-1374. doi:10.1056/nejmoa2507109
BibTeX
@article{Flack2025,
author = {Flack, John M and Azizi, Michel and Brown, Jenifer M and Dwyer, Jamie P and Fronczek, Jakub and Jones, Erika S W and Olsson, Daniel S and Perl, Shira and Shibata, Hirotaka and Wang, Ji-Guang and Wilderäng, Ulrica and Wittes, Janet and Williams, Bryan and BaxHTN Investigators, BaxHTN Investigators},
title = {Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {14},
pages = {1363--1374},
doi = {10.1056/nejmoa2507109}
}
EUVIMED